首页 | 本学科首页   官方微博 | 高级检索  
     

探讨中药治疗原发性血小板增多症的临床评价方法
引用本文:刘松山,张爽. 探讨中药治疗原发性血小板增多症的临床评价方法[J]. 中国新药杂志, 2011, 0(18)
作者姓名:刘松山  张爽
作者单位:成都中医药大学附属医院;
摘    要:
原发性血小板增多症(ET)属血液系统疾病,目前仍无中药治疗ET规范的临床评价标准。按照中药新药临床研究指导原则的评价方法,本文提出ET的病例选择标准、临床干预措施、评价指标、疗效判定标准,并强调合理定位对中药临床评价ET的重要性。

关 键 词:原发性血小板增多症  临床评价  中药  

Clinical methods for evaluating efficacy of Chinese herbal medicines on essential thrombocythemia
LIU Song-shan,ZHANG Shuang. Clinical methods for evaluating efficacy of Chinese herbal medicines on essential thrombocythemia[J]. Chinese Journal of New Drugs, 2011, 0(18)
Authors:LIU Song-shan  ZHANG Shuang
Affiliation:LIU Song-shan,ZHANG Shuang(The Affiliated Hospital to Chengdu Traditional Chinese Medicine University,Chengdu 610072,China)
Abstract:
Essential thrombocythemia(ET) is one of the hematological diseases.Up to date,uniform clinical evaluation standards for ET treatment with Chinese herbal medicines are still lack.In this paper,we proposed the evaluation methods based on the Guidance Principle of Clinical Study on Traditional Chinese Herbal Medicines.The methods include the cases selection criteria,prophylactic and therapeutic measures,evalution index,therapeutic method,and efficacy evaluation standards of ET.We emphasized the importance of r...
Keywords:essential thrombocythemia(ET)  clinical evaluation  Chinese herbal medicine  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号